CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4 enrolled
Drug / intervention
Pointdexterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05038566
NCT05038566N/ACompleted
CompareCT.gov

Dexterous Partial Hand Prosthesis Outcomes

Liberating Technologies, Inc.·interventional·Posted Sep 9, 2021·Updated Jan 17, 2025

In Brief

A clinical study evaluating Pointdexter for Amputation and 4 related conditions. Completed, enrolled 4 participants across 2 sites.

Detailed Summary

Liberating Technologies, Inc. (LTI) has developed a dexterous prosthetic fingertip that will be fit onto an i-Digits™ partial hand prosthesis and allow for an additional fine grasp. The device will interface with research participants' existing prostheses and use the same control strategy that is used for their everyday use. Each participant's prosthesis will be restored to their original configuration by the end of their testing period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmputation, Amputation; Traumatic, Hand, Limb; Absence, Congenital, Upper, Prosthesis User, Upper Limb Amputation at the Hand
CountriesUnited States
CollaboratorsÖssur Iceland ehf

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 9, 2021
Enrollment StartJul 15, 2021
Primary CompletionApr 28, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.8 years ago

Interventions

Pointdexterdevice

i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.